New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Given that alcohol is the most frequent functional group found in bioactive natural products and marketed drugs, and is a ...

Patients receiving an immune checkpoint inhibitor for a neoplasm face an increased risk for rheumatoid arthritis, an observational study found.

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

Name of the Project Advanced thorium extraction facility (ATEF). Location Bessines-sur-Gartempe in Haute-Vienne, western France. Project Owner/s Orano Group subsidiary Orano Med. Project Description ...

Kiniksa Pharmaceuticals stock is attractive because it trades near 52-week lows, and its marketed drug gains traction. Click to find out why KNSA is a Hold.

New research represents a notable step forward in designing enzymes from scratch. With their approach, the authors designed an enzyme that uses a ...

We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, while malaria can give you fever, chills, or nausea, for example. These ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.